DNA, D(P-THIO)(T-G-A-C-T-G-T-G-A-A-C-G-T-T-C-G-A-G-A-T-G-A) UNCOSASODIUM
Ovarian Cancer
PhotonPharma, Inc.nucleic_acidPhase 1Active
C
36/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 59/ 100
Competitive context
439 Active assets in the Ovarian Cancer cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Olaparib Shandong University | Phase 4 | BB |
Inno-206 Genmab | Phase 3 | BB |
Irinotecan ARCAGY/ GINECO GROUP | Phase 4 | BB |
Carboplatin Fudan University | Phase 4 | BB |
(+)-VINCRISTINE ARCAGY/ GINECO GROUP | Phase 4 | BB |
View all 50 →
Same molecule, other indications
DNA, D(P-THIO)(T-G-A-C-T-G-T-G-A-A-C-G-T-T-C-G-A-G-A-T-G-A) UNCOSASODIUM is also rated in:
Recurrent Epithelial Ovarian Cancer Which Includes Epithelial Ovarian, Fallopian Tube and/or Primary Peritoneal CancerDormant
CC
Indicative ·
43 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →